Moore Capital Management’s Lombard Medical, Inc. EVAR Stock Holding History

Moore Capital Management’s Portfolio EVAR Stock Details EVAR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-45,000	Closed	-$293K	–	496
2014 Q4	$293K	Hold	45,000	–	–	0.01%	294
2014 Q3	$346K	Sell	45,000 -9,000	-17%	-$59.5K	0.01%	380
2014 Q2	$388K	Buy	+54,000	New	+$440K	0.01%	446

Other funds holding EVAR

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

Moore Capital Management's EVAR Position: Q1 2015 in Review

Moore Capital Management sold out of Lombard Medical, Inc. (EVAR) in Q1 2015, closing a stake of 45,000 shares — an estimated $293K sold.

Moore Capital Management first reported a position in EVAR in Q2 2014 and held it in 3 quarters. The position peaked at $388K in Q2 2014. 18 funds tracked by Wall St. Rank hold EVAR as of Q1 2015.

Moore Capital Management reported no remaining Lombard Medical, Inc. position as of Q1 2015 after selling out during the quarter.
Moore Capital Management sold 45,000 Lombard Medical, Inc. shares in Q1 2015, an estimated $293K.
Moore Capital Management first reported a position in Lombard Medical, Inc. in Q2 2014 and held it in 3 quarters.
Moore Capital Management's Lombard Medical, Inc. position peaked at $388K in Q2 2014.
18 funds tracked by Wall St. Rank held Lombard Medical, Inc. as of Q1 2015.

Based on Moore Capital Management's 13F filing for Q1 2015, filed 15 May 2015.